Wednesday, September 1, 2010

iPhone Medical News

iPhone Medical News


iPhone App "NovoDose" Helps Physicians Determine Insulin Needs

Posted: 01 Sep 2010 04:23 AM PDT

9n59sb11.jpgNovo Nordisk recently released an iPhone app meant to help physicians determine the insulin needs of their diabetic patients. The app is meant for healthcare professionals (it starts by asking if you really are a healthcare professional), but anyone may download it. The app conveniently assumes you will be using Novo Nordisk's insulin analog product line which includes their long acting (Levemir), short acting (NovoLog) and their NovoLog Mix 70/30.

From the press release:

Novo Nordisk announced today the availability of NovoDose™ – the first-ever mobile insulin dosing guide for physicians to look up dosing guidelines and blood glucose goals for their patients with diabetes, a disease that affects nearly 24 million Americans. The guide is available as an application on iTunes and is specific to Novo Nordisk’s modern insulin analog portfolio: Levemir® (insulin detemir [rDNA origin] injection), NovoLog® (insulin aspart [rDNA origin] injection), and NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]).

The app itself is pretty looking, but not particularly functional. It contains some basic information about the different insulin analogs, suggestions for titrating and calculating mealtime doses, and some studies backing up the recommendations. It is reminiscent of a pharma pamphlet in its presentation. It does not contain any calculators or input functions. The app might be helpful at times in an outpatient setting, but it is not the comprehensive insulin dosing calculator that health professionals might be looking for.

Product page: NovoDose...

iTunes link...

Press release: Novo Nordisk Creates "App" to Help Doctors Dose Insulin, Supporting New Trend in Diabetes Care...



Ins and Outs

Posted: 01 Sep 2010 01:00 AM PDT

For your consideration, here are the latest hand-picked links that didn't make to our posts:

Minnesota Balks at Health-Law Funds ... [WSJ]
J&J [DePuy] recalls 2 hip replacement systems for problems ... [AP]
Study: African-Americans treated with drug-eluting stents at higher risk for blood clots ... [MassDevice]
Monkeypox emerges in Africa in the wake of smallpox ... [Nature Blogs]
Social media can be device makers' best friends ... [MassDevice]
Philips adds to its healthcare lighting portfolio with the acquisition of Burton ... [Philips]
Randomized Controlled Trial Finds Masimo PVI Improves Fluid Management During Surgery ... [Masimo]
CORDIS announces results of ten-year CYPHER® Sirolimus-eluting coronary stent follow-up ... [J&J]
FDA launches new organizational performance management system ... [FDA]
Epocrates adds multi-tasking support to iOS 4... [iMedicalApps]
Study Suggests Importance of Screening For BRCA Gene Mutations ... [WSJ]
NETs catch platelets and induce clots, linking inflammation with thrombosis ... [Children's Hospital Boston]
Antibody-based proteomics: fast-tracking molecular diagnostics in oncology... [Nature Reviews Cancer]
Rheumatoid cachexia and cardiovascular disease... [Nature Reviews Rheumatology]
Researchers Link Protein to Tumor Growth... [Johns Hopkins]
Genetic Stutter Increases Risk of ALS ... [HHMI]
Ichthyosis With Confetti: The skin disease that cures itself ... [Nature]
Fruit Flies Use Horizontal Landmarks for Altitude Control... [Caltech]
Scientists Discover How Chemical Repellants Trip Up Insects ... [Johns Hopkins]
Mosquitoes use several different kinds of odor sensors to track human prey ... [PLoS Biology]
Scalpels and skulls point to Bronze Age brain surgery ... [New Scientist]
The Curious World of Bedbug Research ... [NYTimes.com]
Theaters, Planes to Post Calories ... [WSJ]



No comments:

Post a Comment